These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The analysis of small-sample multivariate data with applications in clinical trials. Mercante DE; Johnson WD J Biopharm Stat; 1993 Sep; 3(2):141-52. PubMed ID: 8220399 [TBL] [Abstract][Full Text] [Related]
5. Dropouts and missing data in psychiatric clinical trials. Potkin SG; Siu CO Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237 [No Abstract] [Full Text] [Related]
6. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F; Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052 [No Abstract] [Full Text] [Related]
8. Analysis of clinical data with breached blindness. Chow SC; Shao J Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477 [TBL] [Abstract][Full Text] [Related]
9. Multivariate nonparametric analysis for the two-period crossover design with application in clinical trials. Johnson WD; Grender JM J Biopharm Stat; 1993 Mar; 3(1):1-12. PubMed ID: 8485530 [TBL] [Abstract][Full Text] [Related]
10. Statistical methodology for clinical trials of caries prophylactic agents--current knowledge. Worthington H Int Dent J; 1984 Dec; 34(4):278-84. PubMed ID: 6597135 [TBL] [Abstract][Full Text] [Related]
11. Alternative analyses for antiepileptic drug trials. Pledger GW; Sahlroot JT Epilepsy Res Suppl; 1993; 10():167-74. PubMed ID: 8251092 [No Abstract] [Full Text] [Related]
12. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F; Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053 [No Abstract] [Full Text] [Related]
13. Methodology of superiority vs. equivalence trials and non-inferiority trials. Christensen E J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447 [TBL] [Abstract][Full Text] [Related]
14. Randomization as a basis for inference in noninferiority trials. Wiens BL Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425 [TBL] [Abstract][Full Text] [Related]
15. Statistical trial designs and clinical practice: are they compatible? Punt CJ Onkologie; 2003 Dec; 26(6):518-9. PubMed ID: 14709922 [No Abstract] [Full Text] [Related]
16. Hypothesis testing in clinical trials. Green SB Hematol Oncol Clin North Am; 2000 Aug; 14(4):785-95, vii-viii. PubMed ID: 10949773 [TBL] [Abstract][Full Text] [Related]
18. Time to rethink clinically important outcomes in platelet transfusion trials. Heddle NM; Arnold DM; Webert KE Transfusion; 2011 Feb; 51(2):430-4. PubMed ID: 21309780 [No Abstract] [Full Text] [Related]
19. Sample size calculation for the Power Model for dose proportionality studies. Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313 [TBL] [Abstract][Full Text] [Related]
20. The use of misclassification models in the evaluation of caries clinical trials. Reed GF J Dent Res; 1984 May; 63 Spec No():727-30. PubMed ID: 6586776 [No Abstract] [Full Text] [Related] [Next] [New Search]